Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations

SIMPLE SUMMARY: The treatment of advanced and metastatic non-small cell lung cancer (NSCLC) has changed dramatically in recent years due to advanced molecular diagnostics and the recognition of targetable oncogenic driver alterations. This has led to the development of very effective new targeted ag...

Descripción completa

Detalles Bibliográficos
Autores principales: König, David, Savic Prince, Spasenija, Rothschild, Sacha I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918961/
https://www.ncbi.nlm.nih.gov/pubmed/33671873
http://dx.doi.org/10.3390/cancers13040804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918961/
https://www.ncbi.nlm.nih.gov/pubmed/33671873
http://dx.doi.org/10.3390/cancers13040804

Ejemplares similares